242 related articles for article (PubMed ID: 19594748)
1. NKG2D-mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes.
Hanaoka N; Nakakuma H; Horikawa K; Nagakura S; Tsuzuki Y; Shimanuki M; Kojima K; Yonemura Y; Kawaguchi T
Br J Haematol; 2009 Sep; 146(5):538-45. PubMed ID: 19594748
[TBL] [Abstract][Full Text] [Related]
2. Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP.
Hanaoka N; Kawaguchi T; Horikawa K; Nagakura S; Mitsuya H; Nakakuma H
Blood; 2006 Feb; 107(3):1184-91. PubMed ID: 16195329
[TBL] [Abstract][Full Text] [Related]
3. Soluble NKG2D Ligands Are Potential Biomarkers and Sentinels of Immune-Mediated Bone Marrow Injury in Bone Marrow Failure Syndromes.
Murata S; Mushino T; Hosoi H; Kuriyama K; Nishikawa A; Nagakura S; Horikawa K; Yonemura Y; Nakakuma H; Sonoki T; Hanaoka N
Acta Haematol; 2020; 143(1):33-39. PubMed ID: 31216534
[TBL] [Abstract][Full Text] [Related]
4. Analysis of abnormal clones by the fluorescent aerolysin method in paroxysmal nocturnal haemoglobinuria and other marrow disorders.
Agarwal R; Chapple P; Brown M; Szer J; Juneja S
Int J Lab Hematol; 2015 Feb; 37(1):14-21. PubMed ID: 24702736
[TBL] [Abstract][Full Text] [Related]
5. T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines.
van Bijnen ST; Withaar M; Preijers F; van der Meer A; de Witte T; Muus P; Dolstra H
Exp Hematol; 2011 Jul; 39(7):751-62.e1-3. PubMed ID: 21554925
[TBL] [Abstract][Full Text] [Related]
6. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.
Maciejewski JP; Follmann D; Nakamura R; Saunthararajah Y; Rivera CE; Simonis T; Brown KE; Barrett JA; Young NS
Blood; 2001 Dec; 98(13):3513-9. PubMed ID: 11739151
[TBL] [Abstract][Full Text] [Related]
7. [Molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria: a role of NKG2D-medicated immunity].
Kawaguchi T
Rinsho Ketsueki; 2010 Aug; 51(8):664-71. PubMed ID: 20805673
[No Abstract] [Full Text] [Related]
8. Killer immunoglobulin-like receptor genotype in immune-mediated bone marrow failure syndromes.
Howe EC; Wlodarski M; Ball EJ; Rybicki L; Maciejewski JP
Exp Hematol; 2005 Nov; 33(11):1357-62. PubMed ID: 16263420
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome.
Horikawa K; Nakakuma H; Kawaguchi T; Iwamoto N; Nagakura S; Kagimoto T; Takatsuki K
Blood; 1997 Oct; 90(7):2716-22. PubMed ID: 9326238
[TBL] [Abstract][Full Text] [Related]
10. Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones.
Maciejewski JP; Rivera C; Kook H; Dunn D; Young NS
Br J Haematol; 2001 Dec; 115(4):1015-22. PubMed ID: 11843844
[TBL] [Abstract][Full Text] [Related]
11. A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.
Mannelli F; Bencini S; Peruzzi B; Cutini I; Sanna A; Benelli M; Magi A; Gianfaldoni G; Rotunno G; Carrai V; Gelli AM; Valle V; Santini V; Notaro R; Luzzatto L; Bosi A
Cytometry B Clin Cytom; 2013 Mar; 84(2):71-81. PubMed ID: 23281097
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
[TBL] [Abstract][Full Text] [Related]
13. Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70.
Bae JH; Kim JY; Kim MJ; Chang SH; Park YS; Son CH; Park SJ; Chung JS; Lee EY; Kim SH; Kang CD
J Immunother; 2010 May; 33(4):391-401. PubMed ID: 20386467
[TBL] [Abstract][Full Text] [Related]
14. Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.
Xuan XY; Zhang JF; Hu GM; Li QR; Liu PP; Du Y
Cancer Gene Ther; 2015 Jul; 22(7):368-74. PubMed ID: 26113176
[TBL] [Abstract][Full Text] [Related]
15. New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.
Kawaguchi T; Nakakuma H
Int J Hematol; 2007 Jul; 86(1):27-32. PubMed ID: 17675263
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study.
Kulagin A; Lisukov I; Ivanova M; Golubovskaya I; Kruchkova I; Bondarenko S; Vavilov V; Stancheva N; Babenko E; Sipol A; Pronkina N; Kozlov V; Afanasyev B
Br J Haematol; 2014 Feb; 164(4):546-54. PubMed ID: 24261566
[TBL] [Abstract][Full Text] [Related]
17. Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure.
Sugimori C; Mochizuki K; Qi Z; Sugimori N; Ishiyama K; Kondo Y; Yamazaki H; Takami A; Okumura H; Nakao S
Br J Haematol; 2009 Oct; 147(1):102-12. PubMed ID: 19656154
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
[TBL] [Abstract][Full Text] [Related]
19. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
[TBL] [Abstract][Full Text] [Related]
20. Differential Expression of CD52, CD14 and HLA-DR on CD4+ Monocytes in Three Types of Acquired Bone Marrow Failure Syndromes.
Kai Y; Yuanyuan D; Shihe G; Xuanxuan M; Hao Z; Ying P; Yuanyuan W; Aihua W; Beibei S; TongYang ; Tingdong Z
Clin Lab; 2016 Sep; 62(9):1767-1772. PubMed ID: 28164595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
